Sağlık bülteni
Güvenilir kurumların yayın akışlarından otomatik derlenir; saatte bir güncellenir. Haberin tamamı için kaynağa gidin. Başlıklar kaynak dilinde (İngilizce) gösterilir.
ABD Gıda ve İlaç Dairesi (FDA) · 09.11.2026
FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High RiskFDA today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent…
ABD Gıda ve İlaç Dairesi (FDA) · 05.11.2026
FDA Grants Accelerated Approval to a New Treatment for Head and Neck Squamous Cell CarcinomaThe U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell…
ABD Gıda ve İlaç Dairesi (FDA) · 02.11.2026
FDA Provides Clarity to Support Cell and Gene Therapy Development and QualityThe U.S. Food and Drug Administration today issued final guidance for manufacturers of cellular and gene therapy (CGT) products to implement a comprehensive, science- and risk-based plan for making sure their…
ABD Gıda ve İlaç Dairesi (FDA) · 30.10.2026
FDA Approves First Plasmid DNA-based Immunotherapy for Adults with Recurrent Respiratory PapillomatosisThe U.S. Food and Drug Administration today granted accelerated approval for Voceryq (doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd) for treatment of adults with recurrent respiratory papillomatosis (RRP).
ABD Gıda ve İlaç Dairesi (FDA) · 22.10.2026
FDA Launches New Program to Advance Neuroscience Medical Product DevelopmentFDA announces the launch of the Neuroscience Advancement and Innovation Nexus (NAIN), a new agency program aligned with the Trump Administration’s efforts to accelerate medical innovation and deliver breakthrough…
ABD Gıda ve İlaç Dairesi (FDA) · 20.10.2026
FDA Approves First-of-Its-Kind Chronic Hepatitis B TreatmentFDA today approved Hibsago (bepirovirsen) injection, in combination with existing antiviral therapy, to treat chronic hepatitis B virus (HBV) infection in certain adults without cirrhosis.
ABD Gıda ve İlaç Dairesi (FDA) · 20.10.2026
FDA Approves Once-Weekly Generic Hormone Therapy Patch for WomenToday, the U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with…
ABD Gıda ve İlaç Dairesi (FDA) · 20.10.2026
FDA Issues Final Guidance on Prescription Drug Apps and SoftwareThe U.S. Food and Drug Administration today released final guidance establishing a clear framework for how drug companies can develop, distribute, and label apps used alongside their prescription medicines.
ABD Gıda ve İlaç Dairesi (FDA) · 19.10.2026
FDA Approves Immunotherapy That May Allow Certain Patients with Rectal Cancer to Avoid Chemotherapy, Radiation and SurgeryThe U.S. Food and Drug Administration today granted accelerated approval for a new use of the immunotherapy Jemperli (dostarlimab-gxly) that may allow some patients with locally advanced rectal cancer to avoid common…
Avrupa Hastalık Önleme ve Kontrol Merkezi (ECDC) · 19.10.2026
Ebola disease: Multi-country outbreak 2026Since May 2026, an Ebola virus disease outbreak caused by Bundibugyo virus has been ongoing in the Democratic Republic of the Congo (DRC).
ABD Gıda ve İlaç Dairesi (FDA) · 14.10.2026
FDA Launches the Rare Disease Framework Initiative to Develop a Holistic, Fit-For-Purpose Framework for Rare Disease Drug DevelopmentThe U.S. Food and Drug Administration, a division within the U.S. Department of Health and Human Services (HHS), today announced the Rare Disease Framework Initiative to reimagine the development of drugs and…
ABD Gıda ve İlaç Dairesi (FDA) · 14.10.2026
FDA Approves First Treatment for Certain People With BCG-Unresponsive Bladder CancerFDA Approves First Treatment for Certain People With BCG-Unresponsive Bladder Cancer
Dünya Sağlık Örgütü (WHO) · 10.10.2026
New WHO technical package to help countries improve health data for COVID-19 response and beyondToday, as part of its commitment to strengthening health information systems and improving health[1], especially in the context of the COVID-19 pandemic, WHO announced a new approach to improving access to…
Avrupa Hastalık Önleme ve Kontrol Merkezi (ECDC) · 05.10.2026
Chikungunya virus disease worldwide overviewEvery month ECDC provides detailed epidemiological overview of the worldwide transmission of chikungunya virus disease in its weekly threat report (Communicable Diseases Threat Report).
ABD Gıda ve İlaç Dairesi (FDA) · 05.10.2026
FDA Seeks Public Input to Support Ibogaine ResearchThe U.S. Food and Drug Administration today announced a request for information (RFI) describing approaches the agency is considering for the design of early-phase clinical trials of ibogaine drug products and…
ABD Gıda ve İlaç Dairesi (FDA) · 01.10.2026
FDA Approves First Heart Valve Designed to Grow with ChildrenThe U.S. Food and Drug Administration today approved the Autus Size-Adjustable Valve, a surgically implanted pulmonary heart valve for pediatric patients with congenital pulmonary valve disease.
ABD Gıda ve İlaç Dairesi (FDA) · 30.09.2026
FDA Launches Nationwide Effort to Expand Scientific Expertise and Consumer Voices to Advisory CommitteesThe U.S. Food and Drug Administration today announced a broad, nationwide recruitment effort to expand the range of qualified voices and perspectives on its advisory committees— the independent bodies that inform…
ABD Gıda ve İlaç Dairesi (FDA) · 29.09.2026
FDA Investigation Leads to Charges Against Two Indian Nationals Involved in Transnational Counterfeit Drug Distribution SchemeThe U.S. Attorney’s Office for the Middle District of Florida and the Criminal Division of the U.S. Department of Justice today announced federal charges against Swapnadip Roy, 33, and Vicky Ramancha, 37, both Indian…
ABD Gıda ve İlaç Dairesi (FDA) · 28.09.2026
FDA Approves First Treatment for MCT8 DeficiencyThe U.S. Food and Drug Administration today approved Emcitate (tiratricol) tablets for oral suspension to treat peripheral thyrotoxicosis (excess thyroid hormone levels in the blood that causes symptoms, such as…
ABD Gıda ve İlaç Dairesi (FDA) · 28.09.2026
FDA intends to evaluate changes to the PMTA regulatory frameworkFDA is carefully reviewing its experience implementing the Premarket Tobacco Product Application (PMTA) rule, as well as recent judicial developments, including a federal lawsuit filed in the U.S. District Court for…
Avrupa Hastalık Önleme ve Kontrol Merkezi (ECDC) · 28.09.2026
Dengue worldwide overviewEvery month ECDC provides detailed epidemiological overview of the worldwide transmission of dengue in its weekly threat report (Communicable Diseases Threat Report).
ABD Gıda ve İlaç Dairesi (FDA) · 23.09.2026
Federal Court Enters Consent Decree Against Gold Star Distribution, Inc. Following Persistent Insanitary Warehouse ConditionsA U.S. Food and Drug Administration investigation resulted in a federal court order, dated Sept. 21, 2026, stopping a warehouse operator from distributing FDA-regulated products including food, drugs, medical…
ABD Gıda ve İlaç Dairesi (FDA) · 21.09.2026
FDA Updates Regulations to Advance Innovative Alternatives to Animal TestingThe FDA today issued a direct final rule that updates its regulations to clarify that non-animal methods can be used where appropriate for testing the safety of drugs and biological products intended for human use…
ABD Gıda ve İlaç Dairesi (FDA) · 17.09.2026
FDA Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type AThe U.S. Food and Drug Administration today approved Fayuvi (rebisufligene etisparvovec-hopf), the first treatment for pediatric patients with mucopolysaccharidosis type IIIA (MPS IIIA), also known as Sanfilippo…
Avrupa Hastalık Önleme ve Kontrol Merkezi (ECDC) · 20.08.2026
Epidemiological update – 11 August 2026: Imported case of Andes hantavirus in the EU/EEAOn 6 August 2026, French public health authorities reported an imported case of Andes hantavirus infection in a traveller from Argentina.
Avrupa Hastalık Önleme ve Kontrol Merkezi (ECDC) · 26.05.2026
Andes hantavirus outbreak in cruise shipECDC was notified on 2 May 2026 of a cluster of severe respiratory illness on MV Hondius, a Dutch-flagged cruise ship with passengers and crew from 23 countries, including nine EU/EEA countries. The virus has been…
Avrupa Hastalık Önleme ve Kontrol Merkezi (ECDC) · 20.05.2026
Epidemiological update: Spread of multidrug-resistant and extensively-drug resistant Shigella in EuropeSince 2023, 14 countries have reported more than 2 300 infections caused by multidrug-resistant (MDR) or extensively drug-resistant (XDR) Shigella sonnei and Shigella flexneri to ECDC. Seven genetically distinct…
Avrupa Hastalık Önleme ve Kontrol Merkezi (ECDC) · 13.05.2026
Mpox worldwide overviewEvery month ECDC provides detailed epidemiological overview of the worldwide transmission of mpox in its weekly threat report.
Avrupa Hastalık Önleme ve Kontrol Merkezi (ECDC) · 18.03.2026
Epidemiological update: Shigellosis and other gastrointestinal infections in travellers returning from Cabo VerdeAs of March 2026, over 1 000 confirmed and possible cases of shigellosis and other gastrointestinal infections, including salmonellosis, have been detected in travellers returning from Cabo Verde to several countries…
Avrupa Hastalık Önleme ve Kontrol Merkezi (ECDC) · 19.12.2025
Early estimates of seasonal influenza vaccine effectiveness against influenza requiring medical attention at primary care level in Europe, week 41 - 49, 2025The 2025/26 influenza season has begun earlier than the previous two seasons, driven by the recently-emerged influenza virus A(H3N2) subclade K.
Avrupa Hastalık Önleme ve Kontrol Merkezi (ECDC) · 05.12.2025
Two cases of Middle East respiratory syndrome (MERS) in travellers returning to France from the Arabian PeninsulaOn 3 December 2025, the French Ministry of Health reported two imported human Middle East respiratory syndrome (MERS) cases with travel history to the Arabian Peninsula.
Dünya Sağlık Örgütü (WHO) · 06.10.2020
COVID-19 disrupting mental health services in most countries, WHO surveyThe COVID-19 pandemic has disrupted or halted critical mental health services in 93% of countries worldwide while the demand for mental health is increasing, according to a new WHO survey. The survey of 130 countries…
Dünya Sağlık Örgütü (WHO) · 28.09.2020
Global partnership to make available 120 million affordable, quality COVID-19 rapid tests for low- and middle-income countriesA full access package includes WHO policy guidance on the use of antigen-based rapid diagnostic tests, manufacturer volume guarantees for low and middle-income countries, catalytic funding to assist governments to…
Dünya Sağlık Örgütü (WHO) · 23.09.2020
Managing the COVID-19 infodemic: Promoting healthy behaviours and mitigating the harm from misinformation and disinformationThe Coronavirus disease (COVID-19) is the first pandemic in history in which technology and social media are being used on a massive scale to keep people safe, informed, productive and connected. At the same time,…
Dünya Sağlık Örgütü (WHO) · 15.09.2020
WHO’s three messages for UNGA75As the world comes together at an unprecedented virtual session of the 75th UN General Assembly (UNGA), WHO has three messages to share.
Dünya Sağlık Örgütü (WHO) · 09.09.2020
COVID-19 could reverse decades of progress toward eliminating preventable child deaths, agencies warnWith the number of under-five deaths at an all-time recorded low of 5.2 million in 2019, disruptions in child and maternal health services due to the COVID-19 pandemic are putting millions of additional lives at…
Dünya Sağlık Örgütü (WHO) · 31.08.2020
In WHO global pulse survey, 90% of countries report disruptions to essential health services since COVID-19 pandemicWHO to roll out learning and monitoring tools to improve service provision during pandemic The World Health Organization (WHO) today published a first indicative survey on the impact of COVID-19 on health systems…
Dünya Sağlık Örgütü (WHO) · 24.08.2020
172 countries and multiple candidate vaccines engaged in COVID-19 vaccine Global Access FacilityNine CEPI-supported candidate vaccines are part of the COVAX initiative, with a further nine candidates under evaluation, and procurement conversations on-going with additional producers not currently receiving…
Dünya Sağlık Örgütü (WHO) · 24.08.2020
Global polio eradication initiative applauds WHO African region for wild polio-free certificationToday, the Africa Regional Certification Commission certified the WHO African Region as wild polio-free after four years without a case. With this historic milestone, five of the six WHO regions – representing…
Dünya Sağlık Örgütü (WHO) · 19.08.2020
World Humanitarian Day 2020: A tribute to aid workers on the front linesAmid a global pandemic, unprecedented needs and growing insecurity, aid workers and health-care responders are staying and delivering to the world’s most vulnerable people. Last year was the most violent on…
Kaynaklar: Dünya Sağlık Örgütü (WHO), Avrupa Hastalık Önleme ve Kontrol Merkezi (ECDC), ABD Gıda ve İlaç Dairesi (FDA).